Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang, Peking university, China

Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Anmin Huang

Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.

🎓 Education & Work Experience

  • Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology

  • Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma

🏆 Achievements

  • Research Publications 📚

    • Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering

    • Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis

    • Contributed to the study of tumor immune infiltration and immunotherapy response

  • Patents & Innovations 🧪

    • Holder of two utility model patents for laboratory equipment

    • Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy

    • Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method

🎖 Awards & Honors

  • Recognized for cutting-edge research in oncology and immunotherapy

  • Contributions to novel cancer treatment strategies and immune regulation

Publication Top Notes:

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites

 

Prof. Shing-Hong Liu | Biomedical Award | Best Researcher Award

Prof. Shing-Hong Liu | Biomedical Award | Best Researcher Award 

Prof. Shing-Hong Liu, Chaoyang University of Technology, Taiwan

Shing-Hong Liu is an esteemed academic and researcher in the field of biomedical engineering and computer science. He obtained his B.S. degree in Electronic Engineering from Feng-Jia University, Taiwan, in 1990, followed by an M.S. degree in Biomedical Engineering from National Cheng-Kung University in 1992. In 2002, he earned his Ph.D. from the Department of Electrical and Control Engineering at National Chiao-Tung University, Taiwan. Since August 1994, Dr. Liu has been actively involved in academia, initially as a Lecturer in the Department of Biomedical Engineering at Yuanpei University, Taiwan. He progressed to become an Associate Professor from 2002 to 2008. Currently, he holds the position of Distinguished Professor in the Department of Computer Science and Information Engineering at Chaoyang University of Technology. Dr. Liu’s research focuses on biomedical signal processing, artificial intelligence applications in mobile health (mHealth), and the design of biomedical instruments. He has been recognized for his contributions, being named one of the World’s Top 2% Scientists in 2020. His research projects have received substantial funding, totaling NT$36,329,914, and he has authored 59 papers in SCI journals.

 

Professional Profile:

ORCID

 

Education:

  • B.S. in Electronic Engineering
    • Feng-Jia University, Taizhong, Taiwan, R.O.C.
    • Year of Completion: 1990
  • M.S. in Biomedical Engineering
    • National Cheng-Kung University, Tainan, Taiwan, R.O.C.
    • Year of Completion: 1992
  • Ph.D. in Electrical and Control Engineering
    • National Chiao-Tung University, Hsinchu, Taiwan, R.O.C.
    • Year of Completion: 2002

Work Experience:

  • Lecturer
    • Department of Biomedical Engineering, Yuanpei University, Hsinchu, Taiwan, R.O.C.
    • August 1994 – 2002
  • Associate Professor
    • Department of Biomedical Engineering, Yuanpei University, Hsinchu, Taiwan, R.O.C.
    • 2002 – 2008
  • Distinguished Professor
    • Department of Computer Science and Information Engineering, Chaoyang University of Technology, Taiwan, R.O.C.
    • 2020 – Present

Achievements:

Shing-Hong Liu has been recognized as one of the World’s Top 2% Scientists in 2020. His research interests focus on biomedical signal processing, artificial intelligence for mHealth applications, and the design of biomedical instruments. He has successfully led projects with a total budget of NT 36,329,914 and has published 59 papers in SCI journals.

Publication top Notes:

Predicting Gait Parameters of Leg Movement with sEMG and Accelerometer Using CatBoost Machine Learning

Human Activity Recognition Based on Deep Learning and Micro-Doppler Radar Data

Estimation of Gait Parameters for Adults with Surface Electromyogram Based on Machine Learning Models

A Wearable Assistant Device for the Hearing Impaired to Recognize Emergency Vehicle Sirens with Edge Computing

A Wearable Assistant Device for Hearing Impaired to Recognize Emergency Vehicle Sirens with Edge Computing